Core Viewpoint - Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. has received acceptance from the Shenzhen Stock Exchange for its application to issue convertible bonds to unspecified objects, pending further regulatory approvals [1][2]. Group 1: Company Announcement - The company announced that it received a notification from the Shenzhen Stock Exchange on January 23, 2026, regarding the acceptance of its application for issuing convertible bonds [1]. - The application documents submitted by the company were deemed complete by the Shenzhen Stock Exchange, leading to the decision to accept the application [1]. - The issuance of the convertible bonds is subject to approval from the China Securities Regulatory Commission after passing the review by the Shenzhen Stock Exchange, indicating uncertainty regarding the final approval and timeline [1]. Group 2: Investor Communication - The company commits to timely information disclosure in accordance with relevant laws and regulations as the matter progresses, urging investors to pay attention to investment risks [1].
常州千红生化制药股份有限公司关于向不特定对象发行可转换公司债券申请获得深圳证券交易所受理的公告